Global Plasma Therapy Market

As stated in our extensive report, the Global Plasma Therapy Market accounted for USD 359.8 Billion in 2022 and is projected to reach a value of USD 653.5 Billion by 2030.

Various reasons have attributed to the continuous expansion of the worldwide Plasma Therapy Market in recent years. Among other infectious diseases, Plasma Therapy has shown promise in treating COVID-19, Ebola, and influenza. One of the main reasons driving the expansion of the Plasma Therapy Market is the rise in patients with infectious disorders. Additionally, it is hoped that technological developments in plasma collection and fractionation, such as the advent of automated plasma separators, may accelerate the uptake of Plasma Therapy. Additionally, the market is expected to grow due to numerous regulatory recommendations for plasmapheresis and blood transfusion adopted by various regulatory agencies, including the US FDA and the European Commission.

Click To Get a Free Sample On the Research Study

Key factors influencing Plasma Therapy Market Growth

The growth of the global Plasma Therapy market can be attributable to the following:

  1. The market for Plasma Therapy is expanding due to the increasing prevalence of chronic diseases such as cancer, autoimmune conditions, and infectious diseases. Patients and medical experts are increasingly interested in Plasma Therapy as a potential treatment for various illnesses.
  2. Technological developments in plasma fractionation techniques have made it possible to produce highly purified plasma-derived therapeutic agents, broadening the application of plasma treatment. The market for Plasma Therapy is anticipated to rise in the upcoming years due to the development of novel plasma-derived products and therapies.
  3. As the advantages of Intravenous immunoglobulin (IVIG) therapy become more well-known, there has been an increase in demand for IVIGs on a global scale. Immunodeficiencies, neurological illnesses, autoimmune diseases, and other conditions are among those that are frequently treated with IVIG. The market for Plasma Therapy is expanding due to the increasing demand for IVIG.
  4. Plasma Therapy uses the patient’s plasma or plasma-derived products to offer personalized treatment options. The market for Plasma Therapy is anticipated to grow due to the rising demand for targeted therapies and personalized medicine.
  5. Many pharmaceutical and biotechnology firms are investing significantly in Plasma Therapy-related research and development projects. This investment fosters innovation and the creation of cutting-edge therapeutic products, accelerating market expansion.

North America Region to Lead the Market

North America Plasma Therapy market is getting more notable, with the highest market sales during the projected period due to factors including the existence of major market participants, a sizable patient population, and an increase in research and development efforts. The market for Plasma Therapy in North America is also significantly influenced by the favorable reimbursement environment. The largest market in the area and a sizable contributor to the global Plasma Therapy Market is the United States. The nation is seeing an increase in the use of cutting-edge plasma-based treatments for a number of illnesses, including hemophilia, immunological deficiencies, and liver disease. When creating cutting-edge technologies for Plasma Therapy, North America has been at the forefront. For instance, North American businesses have created cutting-edge methods to isolate and purify plasma components, such as platelet-rich plasma (PRP) and plasma-derived therapies. These developments have greatly impacted the expansion and success of the Plasma Therapy market in the area. In addition, the region’s highly developed healthcare infrastructure and rising healthcare costs foster market expansion.


The overall Plasma Therapy market sales have been favorably impacted by the increasing prevalence of chronic diseases, advancements in plasma fractionation technology, growing demand for intravenous immunoglobulins (IVIG), and increasing use of Plasma Therapy in wound healing.

The well-known players of the Global Plasma Therapy Market include Cambryn Biologics LLC (U.S.), BioLife Plasma Services (U.S.), CSL Ltd. (Australia), Biotest Pharmaceuticals (Germany), Kedrion S.P.A. (Italy), Grifols International S.A. (Spain), China Biologic Products Inc. (China), LFB Plasma (U.S.) and others.